275 related articles for article (PubMed ID: 3013591)
21. Effects of passive immunization against parathyroid hormone (PTH)-like peptide and PTH in hypercalcemic tumor-bearing rats and normocalcemic controls.
Henderson J; Bernier S; D'Amour P; Goltzman D
Endocrinology; 1990 Sep; 127(3):1310-8. PubMed ID: 2167215
[TBL] [Abstract][Full Text] [Related]
22. Dependence of humoral hypercalcemia of malignancy on parathyroid hormone-related protein expression in the canine anal sac apocrine gland adenocarcinoma (CAC-8) nude mouse model.
Gröne A; Weckmann MT; Blomme EA; Capen CC; Rosol TJ
Vet Pathol; 1998 Sep; 35(5):344-51. PubMed ID: 9754539
[TBL] [Abstract][Full Text] [Related]
23. Hypercalcemia in dogs with adenocarcinoma derived from apocrine glands of the anal sac. Biochemical and histomorphometric investigations.
Meuten DJ; Segre GV; Capen CC; Kociba GJ; Voelkel EF; Levine L; Tashjian AH; Chew DJ; Nagode LA
Lab Invest; 1983 Apr; 48(4):428-35. PubMed ID: 6300551
[TBL] [Abstract][Full Text] [Related]
24. Increased renal calcium reabsorption in an animal model of hypercalcemia of human malignancy.
Shipley PJ; Shevrin DH; Kukreja SC
J Bone Miner Res; 1988 Oct; 3(5):555-60. PubMed ID: 3195367
[TBL] [Abstract][Full Text] [Related]
25. Bone and kidney adenylate cyclase-stimulating activity produced by a hypercalcemic canine adenocarcinoma line (CAC-8) maintained in nude mice.
Rosol TJ; Capen CC; Brooks CL
Cancer Res; 1987 Feb; 47(3):690-5. PubMed ID: 3467838
[TBL] [Abstract][Full Text] [Related]
26. The hypercalciurias. Causes, parathyroid functions, and diagnostic criteria.
Pak CY; Oata M; Lawrence EC; Snyder W
J Clin Invest; 1974 Aug; 54(2):387-400. PubMed ID: 4367891
[TBL] [Abstract][Full Text] [Related]
27. Interleukin-4 inhibits spontaneous and parathyroid hormone-related protein-stimulated osteoclast formation in mice.
Nakano Y; Watanabe K; Morimoto I; Okada Y; Ura K; Sato K; Kasono K; Nakamura T; Eto S
J Bone Miner Res; 1994 Oct; 9(10):1533-9. PubMed ID: 7817798
[TBL] [Abstract][Full Text] [Related]
28. Tumor necrosis factor enhances parathyroid hormone-related protein-induced hypercalcemia and bone resorption without inhibiting bone formation in vivo.
Uy HL; Mundy GR; Boyce BF; Story BM; Dunstan CR; Yin JJ; Roodman GD; Guise TA
Cancer Res; 1997 Aug; 57(15):3194-9. PubMed ID: 9242449
[TBL] [Abstract][Full Text] [Related]
29. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.
Onuma E; Azuma Y; Saito H; Tsunenari T; Watanabe T; Hirabayashi M; Sato K; Yamada-Okabe H; Ogata E
Clin Cancer Res; 2005 Jun; 11(11):4198-203. PubMed ID: 15930357
[TBL] [Abstract][Full Text] [Related]
30. Expression of human transforming growth factor alpha by Chinese hamster ovarian tumors in nude mice causes hypercalcemia and increased osteoclastic bone resorption.
Yates AJ; Boyce BF; Favarato G; Aufdemorte TB; Marcelli C; Kester MB; Walker R; Langton BC; Bonewald LF; Mundy GR
J Bone Miner Res; 1992 Jul; 7(7):847-53. PubMed ID: 1642153
[TBL] [Abstract][Full Text] [Related]
31. Tumors producing human tumor necrosis factor induced hypercalcemia and osteoclastic bone resorption in nude mice.
Johnson RA; Boyce BF; Mundy GR; Roodman GD
Endocrinology; 1989 Mar; 124(3):1424-7. PubMed ID: 2917519
[TBL] [Abstract][Full Text] [Related]
32. Osseous and intestinal compartments in the humoral hypercalcemia of malignancy associated to Walker 256 tumor in rats.
Torres R; de la Piedra C; Rapado A
Oncology; 1993; 50(2):148-52. PubMed ID: 8451038
[TBL] [Abstract][Full Text] [Related]
33. Hypercalcemia and cosecretion of interleukin-6 and parathyroid hormone related peptide by a human renal cell carcinoma implanted into nude mice.
Weissglas M; Schamhart D; Löwik C; Papapoulos S; Vos P; Kurth KH
J Urol; 1995 Mar; 153(3 Pt 1):854-7. PubMed ID: 7861550
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of in vitro bone resorption by a parathyroid hormone receptor antagonist in the canine adenocarcinoma model of humoral hypercalcemia of malignancy.
Rosol TJ; Capen CC
Endocrinology; 1988 May; 122(5):2098-102. PubMed ID: 2834184
[TBL] [Abstract][Full Text] [Related]
35. Quantitative bone histomorphometry in humoral hypercalcemia of malignancy: uncoupling of bone cell activity.
Stewart AF; Vignery A; Silverglate A; Ravin ND; LiVolsi V; Broadus AE; Baron R
J Clin Endocrinol Metab; 1982 Aug; 55(2):219-27. PubMed ID: 7085851
[TBL] [Abstract][Full Text] [Related]
36. Identification of 1,24(R)-dihydroxyvitamin D3-like bone-resorbing lipid in a patient with cancer-associated hypercalcemia.
Shigeno C; Yamamoto I; Dokoh S; Hino M; Aoki J; Yamada K; Morita R; Kameyama M; Torizuka K
J Clin Endocrinol Metab; 1985 Oct; 61(4):761-8. PubMed ID: 2993347
[TBL] [Abstract][Full Text] [Related]
37. Bone resorption and circulating PTH-like bioactivity in an animal model of hypercalcaemia of malignancy.
Mehdizadeh S; Alaghband-Zadeh J; Gusterson B; Arlot M; Bradbeer JN; Loveridge N
Biochem Biophys Res Commun; 1989 Jun; 161(3):1166-71. PubMed ID: 2742581
[TBL] [Abstract][Full Text] [Related]
38. Squamous carcinoma model of humoral hypercalcemia of malignancy.
Gkonos PJ; Hayes T; Burtis W; Jacoby R; McGuire J; Baron R; Stewart AF
Endocrinology; 1984 Dec; 115(6):2384-90. PubMed ID: 6499773
[TBL] [Abstract][Full Text] [Related]
39. A case of temporary severe disequilibrium hypercalcemia.
Kogawa K; Inaba M; Okuno Y; Nishizawa Y; Morii H
Miner Electrolyte Metab; 1994; 20(3):163-8. PubMed ID: 7816007
[TBL] [Abstract][Full Text] [Related]
40. Normalization of hypercalcemia associated with a decrease in renal calcium reabsorption in Leydig cell tumor-bearing rats treated with WR-2721.
Hirschel-Scholz S; Caverzasio J; Rizzoli R; Bonjour JP
J Clin Invest; 1986 Jul; 78(1):319-22. PubMed ID: 3013941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
